Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2026
Reporting Period: The filing references financial information for the three and six months ended June 30, 2026, and includes forward-looking statements for 2026 and beyond.
Key Financial Metrics
The provided text serves as a cover sheet for the filing and does not contain specific numerical data. It states that financial information regarding revenue, profit, cash flow, margins, debt, and liquidity is contained in Exhibit 99.1 (a press release dated July 23, 2026), which is incorporated by reference but not included in the input text. Therefore, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not detail specific material changes versus prior periods. It indicates that such information is presented in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
- Outlook: The filing incorporates forward-looking statements relating to 2026 and beyond, as presented in the press release.
- Legal Status: The information furnished pursuant to Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Management Commentary: Specific commentary is located in the referenced press release and is not present in the main body of this 8-K text.
Investor Verification Checklist
- Verify the specific financial results for the three and six months ended June 30, 2026, by reviewing Exhibit 99.1 (the press release dated July 23, 2026).
- Confirm the details of the forward-looking statements regarding 2026 and beyond found in the referenced press release.
- Note that the financial data in this filing is furnished under Item 2.02 and carries different liability protections than formally filed financial statements.